Extracorporeal medical machines such as the pump oxygenator and artificial kidney rely on systemic heparinization to improve blood compatibility. However, heparin can lead to serious complications such as bleeding. The applicants propose a new method to control heparin levels using a blood filter containing immobilized heparinase. Such a filter might be used in situations where it is desired to heparinize the extracorporeal circuit without simultaneous heparinization of the patient. Alternatively, it could eliminate the use of neutralizing compounds such as protamine. Their research has focused not only on the development and testing of the filter, but on heparinase production and purification as well.
The specific aims of the current proposal are: (1) to employ genetic engineering to produce high levels of heparinase, (2) to improve reactor design, (3) to develop comprehensive in vivo models to predict reactor performance, and (4) to conduct in vivo studies using hemodialysis and cardiovascular models in animals, to assess the safety and efficacy of the proposed approach.
|Ameer, G A; Barabino, G; Sasisekharan, R et al. (1999) Ex vivo evaluation of a Taylor-Couette flow, immobilized heparinase I device for clinical application. Proc Natl Acad Sci U S A 96:2350-5|
|Ameer, G A; Harmon, W; Sasisekharan, R et al. (1999) Investigation of a whole blood fluidized bed Taylor-Couette flow device for enzymatic heparin neutralization. Biotechnol Bioeng 62:602-8|
|Ameer, G A; Raghavan, S; Sasisekharan, R et al. (1999) Regional heparinization via simultaneous separation and reaction in a novel Taylor-Couette flow device. Biotechnol Bioeng 63:618-24|
|Sasisekharan, R; Venkataraman, G; Godavarti, R et al. (1996) Heparinase I from Flavobacterium heparinum. Mapping and characterization of the heparin binding domain. J Biol Chem 271:3124-31|
|Godavarti, R; Cooney, C L; Langer, R et al. (1996) Heparinase I from Flavobacterium heparinum. Identification of a critical histidine residue essential for catalysis as probed by chemical modification and site-directed mutagenesis. Biochemistry 35:6846-52|
|Ernst, S; Venkataraman, G; Winkler, S et al. (1996) Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum. Biochem J 315 ( Pt 2):589-97|
|Venkataraman, G; Sasisekharan, V; Herr, A B et al. (1996) Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation. Proc Natl Acad Sci U S A 93:845-50|
|Ernst, S; Langer, R; Cooney, C L et al. (1995) Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol 30:387-444|
|Shefer, S D; Breslau, J; Langer, R (1995) Computer simulation of low-density lipoprotein removal in the presence of a bioreactor containing phospholipase A2. Biotechnol Prog 11:133-9|
|Sasisekharan, R; Leckband, D; Godavarti, R et al. (1995) Heparinase I from Flavobacterium heparinum: the role of the cysteine residue in catalysis as probed by chemical modification and site-directed mutagenesis. Biochemistry 34:14441-8|
Showing the most recent 10 out of 39 publications